Latest News & Features
Refine Search
Americas
John Rearick is the latest addition to the firm to strengthen its life sciences practice. 11 July 2023
Americas
Commission says that medical device maker’s arguments have broad implications for antitrust enforcement | Dispute concerns alleged exclusive-dealing and bundling arrangements. 5 July 2023
article
The firm’s presence in Shenzhen will expand its focus on tech industries in the region. 5 July 2023
article
Lewis Silkin has integrated MSK into its practice to better manage complex portfolios across various tech sectors. 4 July 2023
Big Pharma
Board did not violate procedure regarding ‘preliminary guidance’ say Federal Circuit judges | Medytox’s substitute claims found to be ‘unpatentable’. 29 June 2023
Big Pharma
UPC Administrative Committee 'voted unanimously' to approve Milan says Italian politician | Court will hear patent cases related to “pharmaceutical, phytosanitary, agri-food and fashion” | Chemistry and metallurgy moving to Munich, excluding SEPs. 27 June 2023
Europe
Dame Sue Carr takes over from Lord Burnett of Maldon, assuming responsibilities in October. 22 June 2023
Americas
Commission argues that a New York federal court erred in its finding that deals between an AbbVie unit and generic manufacturers were justified | US Supreme Court previously ruled that “unjustified” reverse payments can violate the antitrust laws. 22 June 2023
Americas
Pharma company claims infringement of both patents that cover the blockbuster treatment | Generic version has been in motion since May last year. 22 June 2023
Big Pharma
Pharma giant claims infringement of two patents |
Hyderabad-based rival’s letter offering details of proposed generic allegedly lacked certain required details. 20 June 2023